Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile. 2022

Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
Centro de Biotecnología Acuícola, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.

The variant of concern (VOC) SARS-CoV-2 Omicron (B.1.1529) has been described as a highly contagious variant but less virulent than the current variant being monitored (VBM) Delta (B.1.617.2), causing fewer cases of hospitalizations, symptomatology, and deaths associated with COVID-19 disease. Although the epidemiological comparison of both variants has been previously reported in other countries, no report indicates their behavior and severity of infection in Chile. In this work, we report for the first time the effect of the Omicron and Delta variants in a cohort of 588 patients from the Hospital de Urgencia Asistencia pública (HUAP), a high-complexity health center in Santiago, Chile. This report is framed at the beginning of Chile's third wave of the COVID-19 pandemic, with a marked increase in the Omicron variant and a decrease in the circulating Delta variant. Our results indicated a similar proportion of patients with a complete vaccination schedule for both variants. However, the Delta variant was associated with a higher prevalence of hospitalization and more significant symptomatology associated with respiratory distress. On the other hand, our data suggest that vaccination is less effective in preventing infection by the Omicron variant. This antecedent, with a low severity but high contagiousness, suggests that the Omicron variant could even collapse the primary health care service due to the high demand for health care.

UI MeSH Term Description Entries
D002677 Chile A country in southern South America, bordering the South Pacific Ocean, between Argentina and Peru.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
January 2022, Frontiers in immunology,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
December 2022, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
December 2021, MedComm,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
January 2022, Frontiers in medicine,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
October 2022, Vaccines,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
March 2022, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
January 2023, Frontiers in immunology,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
October 2023, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
October 2023, Hospital pediatrics,
Andrea Mella-Torres, and Alejandro Escobar, and Carlos Barrera-Avalos, and Sergio Vargas-Salas, and Michelle Pirazzoli, and Ulises Gonzalez, and Daniel Valdes, and Patricio Rojas, and Roberto Luraschi, and Eva Vallejos-Vidal, and Mónica Imarai, and Ana María Sandino, and Felipe E Reyes-López, and Rodrigo Vera, and Claudio Acuña-Castillo
December 2023, Annals of hematology,
Copied contents to your clipboard!